Why in the News?
The Ministry of Science and Technology has announced the development of PathGennie, a new open-source computational software that can significantly speed up drug discovery by accurately simulating drug–protein unbinding, a crucial step in understanding drug efficacy and safety.
What is PathGennie?
- PathGennie is an open-source computational framework designed to simulate rare molecular events, especially the unbinding of drugs from protein targets.
- It helps in predicting drug residence time, a key parameter that determines how long a drug remains effective inside the body.
- It avoids artificial distortions commonly introduced in conventional simulation methods.
Developed by
- Scientists at the S. N. Bose National Centre for Basic Sciences, Kolkata.
Aim of PathGennie
- To overcome the limitations of traditional molecular dynamics simulations, which struggle to capture slow and rare molecular transitions.
- To generate physically accurate pathways for drug–protein interactions.
- To reduce computational time and cost without compromising accuracy.
Applications
- Predicts accurate drug unbinding pathways and residence times
- Example: Imatinib with Abl kinase
- Improves understanding of protein–ligand kinetics for better drug design
- Applicable beyond drug discovery in: Chemical reactions, Catalysis, Phase transitions and Molecular self-assembly
Prelims Pointers
- PathGennie is open-source and computational in nature
- Focuses on drug unbinding, not just binding
- Helps estimate drug residence time, a key pharmacological parameter
- Avoids artificial bias unlike conventional simulation techniques
- Developed in India under the Ministry of Science and Technology
| [2022] Consider the following:
1. Aarogya Setu 2. CoWIN 3. DigiLocker 4. DIKSHA. Which of the above are built on top of open-source digital platforms? (a) 1 and 2 only (b) 2, 3 and 4 only (c) 1, 3 and 4 only (d) 1, 2, 3 and 4 |
